These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 29152756

  • 1. β-catenin deficiency in hepatocytes aggravates hepatocarcinogenesis driven by oncogenic β-catenin and MET.
    Liang Y, Feng Y, Zong M, Wei XF, Lee J, Feng Y, Li H, Yang GS, Wu ZJ, Fu XD, Feng GS.
    Hepatology; 2018 May; 67(5):1807-1822. PubMed ID: 29152756
    [Abstract] [Full Text] [Related]

  • 2. Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic β-Catenin, PIK3CA and MET.
    Liu JJ, Li Y, Chen WS, Liang Y, Wang G, Zong M, Kaneko K, Xu R, Karin M, Feng GS.
    J Hepatol; 2018 Jul; 69(1):79-88. PubMed ID: 29505847
    [Abstract] [Full Text] [Related]

  • 3. TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis.
    Liang B, Zhou Y, Qian M, Xu M, Wang J, Zhang Y, Song X, Wang H, Lin S, Ren C, Monga SP, Wang B, Evert M, Chen Y, Chen X, Huang Z, Calvisi DF, Chen X.
    J Hepatol; 2021 Jul; 75(1):120-131. PubMed ID: 33577921
    [Abstract] [Full Text] [Related]

  • 4. Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant β-catenin.
    Tao J, Xu E, Zhao Y, Singh S, Li X, Couchy G, Chen X, Zucman-Rossi J, Chikina M, Monga SP.
    Hepatology; 2016 Nov; 64(5):1587-1605. PubMed ID: 27097116
    [Abstract] [Full Text] [Related]

  • 5. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S, Dahmani R, Coulouarn C, Ragazzon B, Mlecnik B, Senni N, Savall M, Bossard P, Sohier P, Drouet V, Tournier E, Dumont F, Sanson R, Calderaro J, Zucman-Rossi J, Vasseur-Cognet M, Just PA, Terris B, Perret C, Gilgenkrantz H.
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [Abstract] [Full Text] [Related]

  • 6. Oncogenic potential of N-terminal deletion and S45Y mutant β-catenin in promoting hepatocellular carcinoma development in mice.
    Qiao Y, Xu M, Tao J, Che L, Cigliano A, Monga SP, Calvisi DF, Chen X.
    BMC Cancer; 2018 Nov 12; 18(1):1093. PubMed ID: 30419856
    [Abstract] [Full Text] [Related]

  • 7. FAK is required for c-Met/β-catenin-driven hepatocarcinogenesis.
    Shang N, Arteaga M, Zaidi A, Stauffer J, Cotler SJ, Zeleznik-Le NJ, Zhang J, Qiu W.
    Hepatology; 2015 Jan 12; 61(1):214-26. PubMed ID: 25163657
    [Abstract] [Full Text] [Related]

  • 8. Single-cell transcriptomics reveals opposing roles of Shp2 in Myc-driven liver tumor cells and microenvironment.
    Chen WS, Liang Y, Zong M, Liu JJ, Kaneko K, Hanley KL, Zhang K, Feng GS.
    Cell Rep; 2021 Nov 09; 37(6):109974. PubMed ID: 34758313
    [Abstract] [Full Text] [Related]

  • 9. FAK Kinase Activity Is Required for the Progression of c-MET/β-Catenin-Driven Hepataocellular Carcinoma.
    Shang N, Arteaga M, Zaidi A, Cotler SJ, Breslin P, Ding X, Kuo P, Nishimura M, Zhang J, Qiu W.
    Gene Expr; 2016 Nov 09; 17(1):79-88. PubMed ID: 27142958
    [Abstract] [Full Text] [Related]

  • 10. Role of insulin receptor substrates in the progression of hepatocellular carcinoma.
    Sakurai Y, Kubota N, Takamoto I, Obata A, Iwamoto M, Hayashi T, Aihara M, Kubota T, Nishihara H, Kadowaki T.
    Sci Rep; 2017 Jul 14; 7(1):5387. PubMed ID: 28710407
    [Abstract] [Full Text] [Related]

  • 11. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
    Zhu C, Ho YJ, Salomao MA, Dapito DH, Bartolome A, Schwabe RF, Lee JS, Lowe SW, Pajvani UB.
    J Hepatol; 2021 Mar 14; 74(3):613-626. PubMed ID: 33038431
    [Abstract] [Full Text] [Related]

  • 12. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
    Toh TB, Lim JJ, Hooi L, Rashid MBMA, Chow EK.
    J Hepatol; 2020 Jan 14; 72(1):104-118. PubMed ID: 31541681
    [Abstract] [Full Text] [Related]

  • 13. Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma.
    Che L, Pilo MG, Cigliano A, Latte G, Simile MM, Ribback S, Dombrowski F, Evert M, Chen X, Calvisi DF.
    Cell Cycle; 2017 Mar 19; 16(6):499-507. PubMed ID: 28118080
    [Abstract] [Full Text] [Related]

  • 14. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
    Li J, Dai X, Zhang H, Zhang W, Sun S, Gao T, Kou Z, Yu H, Guo Y, Du L, Jiang S, Zhang J, Zhou Y.
    Oncotarget; 2015 Oct 06; 6(30):29196-208. PubMed ID: 26470691
    [Abstract] [Full Text] [Related]

  • 15. Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis.
    Bozkaya G, Korhan P, Cokaklı M, Erdal E, Sağol O, Karademir S, Korch C, Atabey N.
    Mol Cancer; 2012 Sep 11; 11():64. PubMed ID: 22962849
    [Abstract] [Full Text] [Related]

  • 16. β-catenin-activated hepatocellular carcinomas are addicted to fatty acids.
    Senni N, Savall M, Cabrerizo Granados D, Alves-Guerra MC, Sartor C, Lagoutte I, Gougelet A, Terris B, Gilgenkrantz H, Perret C, Colnot S, Bossard P.
    Gut; 2019 Feb 11; 68(2):322-334. PubMed ID: 29650531
    [Abstract] [Full Text] [Related]

  • 17. Wnt/beta-catenin signaling activates and determines hepatic zonal expression of glutathione S-transferases in mouse liver.
    Giera S, Braeuning A, Köhle C, Bursch W, Metzger U, Buchmann A, Schwarz M.
    Toxicol Sci; 2010 May 11; 115(1):22-33. PubMed ID: 20118494
    [Abstract] [Full Text] [Related]

  • 18. Nuclear factor erythroid 2-related factor 2 and β-Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic Implications.
    Tao J, Krutsenko Y, Moghe A, Singh S, Poddar M, Bell A, Oertel M, Singhi AD, Geller D, Chen X, Lujambio A, Liu S, Monga SP.
    Hepatology; 2021 Aug 11; 74(2):741-759. PubMed ID: 33529367
    [Abstract] [Full Text] [Related]

  • 19. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
    Amicone L, Terradillos O, Calvo L, Costabile B, Cicchini C, Della Rocca C, Lozupone F, Piacentini M, Buendia MA, Tripodi M.
    Oncogene; 2002 Feb 21; 21(9):1335-45. PubMed ID: 11857077
    [Abstract] [Full Text] [Related]

  • 20. Complete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model.
    Delgado E, Okabe H, Preziosi M, Russell JO, Alvarado TF, Oertel M, Nejak-Bowen KN, Zhang Y, Monga SP.
    J Hepatol; 2015 Feb 21; 62(2):380-7. PubMed ID: 25457204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.